Press Release – Chennai, 21st May 2015: Vaso Meditech Pvt Ltd, the exclusive distributor and clinical support provider for Enhanced External Counter Pulsation in India, announced the inauguration of EECP therapy heart treatment for cardiac patients at the Government Kilpauk Medical College Hospital. The advanced non invasive therapy was introduced in the hospitals Department of Cardiology, marking an important step toward expanding access to modern cardiac care for patients with coronary artery disease and other chronic heart conditions.
Speaking at the inauguration, Dean Dr. Narayana Babu explained that EECP therapy heart treatment functions like a second heart placed in the legs. Through synchronized external compression, the therapy pumps blood from the lower limbs back toward the heart, improving coronary blood circulation and increasing oxygen delivery to the heart muscle. This non invasive approach helps stimulate the development of natural collateral blood vessels, providing additional support for patients with reduced blood flow to the heart.
The inauguration also highlighted the importance of recognizing heart attack symptoms such as chest pain, shortness of breath, pain radiating to the arm or jaw, excessive sweating, and unusual fatigue. Early diagnosis and timely treatment can significantly improve patient outcomes. The availability of EECP therapy heart treatment at Government Kilpauk Medical College Hospital provides eligible patients with an effective non surgical option that complements conventional cardiac care and supports long term heart health.
EECP THERAPY uses a proprietary technology to inflate and deflate a series of pneumatic cuffs enclosing the lower extremities of the patients. Treatment is administered on a padded table in which three sets of electronically controlled inflation and deflation valves are located.
